Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

about

Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population.

P2860

Q36554959-DD66D3A6-E93C-444B-AAD2-66D04104342F

P2860

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

Item

http://www.wikidata.org/entity/Q36153557

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

@ast

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

@en

type

Item

label

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

@ast

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

@en

prefLabel

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

@ast

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

@en

P1476

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

@en

P2093

Maria Cláudia Santos-Silva

http://www.w3.org/2001/XMLSchema#string

Michelle Maccarini Barcelos

http://www.w3.org/2001/XMLSchema#string

P2860

Janus kinases in immune cell signaling

The molecular mechanisms that control thrombopoiesis

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2

Management of polycythemia vera and essential thrombocythemia

Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia

Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders

Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation

P304

290-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5581/1516-8484.20110079

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232226427

http://www.w3.org/2001/XMLSchema#string

P698

23049320

http://www.w3.org/2001/XMLSchema#string

P932

3415756

http://www.w3.org/2001/XMLSchema#string

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

about

P2860

P2860

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932